These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8400044)

  • 1. Pathological findings and prognosis from uterine malignancy.
    Hernandez E
    Curr Opin Obstet Gynecol; 1993 Aug; 5(4):480-5. PubMed ID: 8400044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of the uterine body.
    Fox H
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):568-73. PubMed ID: 1652304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation.
    Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Trope C
    Anticancer Res; 1987; 7(4B):791-7. PubMed ID: 3674764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal cytology and its prognostic value in endometrial carcinoma.
    Ebina Y; Hareyama H; Sakuragh N; Yamamoto R; Furuya M; Sogame M; Fujino T; Makinoda S; Fujimoto S
    Int Surg; 1997; 82(3):244-8. PubMed ID: 9372367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects of endometrial carcinoma.
    Silverberg SG
    Clin Obstet Gynaecol; 1984 Apr; 11(1):189-208. PubMed ID: 6370532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
    Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
    Gynecol Oncol; 1996 Aug; 62(2):254-9. PubMed ID: 8751558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of preoperative endometrial sampling for the detection of uterine sarcomas.
    Bansal N; Herzog TJ; Burke W; Cohen CJ; Wright JD
    Gynecol Oncol; 2008 Jul; 110(1):43-8. PubMed ID: 18445505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer: not a benign disease.
    Boronow RC
    Obstet Gynecol; 1976 May; 47(5):630-4. PubMed ID: 772510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomas of the female genital tract and pelvic soft tissues. A cluster of 14 cases in one year.
    Gleeson N; Gaffney EF; Gonsalves R; Quigley J; Bonnar J
    Ir Med J; 1993; 86(6):196-8. PubMed ID: 8106227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial adenocarcinoma.
    Noumoff JS; Faruqi S
    Microsc Res Tech; 1993 Jun; 25(3):246-54. PubMed ID: 8400424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and morphologic diagnosis of uterine sarcoma].
    Bokhman IaV; Urmancheeva AF; Neustadt EL; Kutusheva GF
    Vopr Onkol; 1998; 44(2):175-80. PubMed ID: 9615822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.